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Introduction
Freely circulating and collectively used testosterone is dynamite for the
heterosexual regime.1
My biopolitical options are as follows: either I declare myself to be a transsexual,
or I declare myself to be drugged and psychotic.2

Last winter, I decided to start actively pursuing what is known as chest masculinization
or “top surgery.” I called a plastic surgeon in New York to request a consultation. While we were
trying to settle on a date, the secretary inquired of me:
“...and you’ve been on testosterone for at least one year, right?”
“No, do I have to be to schedule a consult?”
“Oh yes, the doctor won’t see you for a consultation unless you’ve been on testosterone for one
year and have two letters of recommendation, one from your hormone provider, and one from a
mental health professional.”
I tried to find another surgeon in New York that do the procedure without me fulfilling those
criteria to no avail--the ones that would didn’t accept my insurance, so I would have had to pay
between $7,000-$10,000 out of pocket if I wanted to see them. I requested some forms from my
insurance provider to find out who else was in-network when I realized that my policy said the
same thing: one year of hormone therapy and two letters of recommendation to get top surgery
covered as a treatment for gender dysphoria.
I thought, What the hell, I might as well start taking T (testosterone) if that’s the only way
I can get top surgery. During a visit with my primary care physician to start hormone therapy, I

Paul B. Preciado. Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era. Feminist Press.
2013. 230.
2
Paul B. Preciado. Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era. Feminist Press.
2013. 256.
1
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realized as I was explaining what I wanted to her that she had never had a trans patient before.
She had no answers to the questions that I asked about the effects of testosterone, how much it
would cost, what options I had in terms of the form the medication would come in. I felt
awkward sitting on the padded table explaining myself to her while she looked at me blankly.
When I left with no prescription for testosterone, she referred me to a plastic surgeon who she
said could perform top surgery. When I called the office phone, they said, “No, sorry, the doctor
doesn’t do that kind of surgery.”
Fast forward a few months, and I’ve finally gotten a prescription for testosterone gel from
a trans-friendly provider at a nearby reproductive health clinic. When I go to pick up the
prescription, they tell me it will cost a few hundred dollars because my insurance has not covered
it. After leaving the pharmacy without my prescription, I called my insurance provider and was
on hold for about an hour until someone finally said they had not given a prior-authorization for
the prescription. We exchanged calls more than 30 times over the next two months, and finally, I
was able to pick up my prescription.
A year after being on testosterone, I finally made an appointment with a therapist in order
to get a recommendation for my top surgery. Despite this therapist being trans himself, he
required that I come in three times to talk about my relationship to my gender and my reasons for
wanting surgery. As he was asking me about how long I’ve wanted to get top surgery during one
of our 50-minute long sessions, I couldn’t help but wanting to talk about some other personal
issues causing me stress. I was frustrated by this, particularly because I have been “living as”
trans for well over four years now.

8

As I went through this process, I assembled the research that would become this project.
Many of the materials that I encountered while researching were incredibly painful to look at,
most notably arguments about transition regret and trans-exclusionary radical feminists. It was
very important to me to continue writing this project, and helped me dispel the anxieties I was
having about my choices to pursue hormone therapy and top surgery and be more sure of my
decisions.
On March 13, 2019, I finally was able to get top surgery. My experience, although it was
extremely frustrating and time-consuming, pales in comparison to what many other trans people
go through in order to access the embodiment that they are seeking. Many trans people are not
able to pursue procedures like top surgery precisely because it is so difficult to access. (Unless,
of course, you pay out-of-pocket).
In writing this project, I wanted to speak to the reasons why materializing our desired
embodiments is so inaccessible and difficult for many trans people. I offer an analysis of the
relationship that trans people have to transition-related healthcare in the contemporary United
States that is grounded in historical context, drawing both from the medical profession itself and
the trans people who have interacted with it, placing a particular emphasis on centralizing the
voices of trans people most affected by interlocking systems of oppression on the basis of their
race, class, and sexuality. Chapter 1 focuses on the years between 1950-1979, during which
gender variance was medicalized within medical and popular discourse as a pathology known as
‘transsexualism’ with a set treatment that consisted of counseling, hormone therapy, and surgery.
I argue that endocrinologist Harry Benjamin and famous trans woman Christine Jorgensen were
two figures central to constructing transsexual through invoking notions whiteness,
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heterosexuality, and middle-class sensibility to render it intelligible. Chapter 2 deals with the
standardization and professionalization of the treatment for this pathology that started with the
closure of university-based gender identity clinics in 1979. I argue that the gatekeeping model of
trans healthcare is aimed at controlling, disciplining, and regulating the expression of gender
variance, thereby restricting access to those who can meet strict diagnostic criteria. Chapter 3
argues that privatization of these treatments, which started in the 1980s, and the simultaneous
exclusion from coverage by most major health insurance plans separated the treatment from the
pathology, and constructing medical care as a luxury that only few can afford to access. The
conclusion seeks to imagine an alternative, in which gender variance is demedicalized and
gender affirming care is freely accessible to all those that seek it.

10

Chapter 1
Inventing the Transsexual Phenomenon: Medicalizing Gender Variance in Mid-Twentieth
Century U.S. Medical Discourse and Popular Culture
Being a true physician, Benjamin treated all these patients as people and
by respectfully listening to each individual voice, he learned from them
what gender dysphoria was about. These early patients must be lauded for
their courage in seeking a description of and a solution to a phenomenon
that had as yet no description and no solution. They discovered a
physician who was willing to try to treat their unusual condition in a way
that had never been attempted before.3
Personally, he only did girls he thought would pass. He only did white
girls. Would help those girls. So taller girls like myself had to find other
places. The black girls had to go to other places.4

During the later half of the twentieth century (1948-1979), gender variance was
medicalized within medical discourse as a diagnosable condition known as ‘transsexualism,’
which had one legitimate treatment path. Medical professionals, such as Harry Benjamin, laid
claims to expert knowledge about the ‘transsexual’ condition and dominion over its
management. At the same time, stories and images of trans people emerged and circulated in
newspapers and books, marking the first time that many people in the U.S. would hear about
‘transsexuals.’. How were the ‘symptoms’ of this condition constructed within medical
discourse? What were the goals of treatment? What was at stake in medicalizing gender variance

Leah Cahan Schaefer and Connie Christine Wheeler, "Harry Benjamin's first ten cases (1938-1953): A clinical
historical note." Archives of Sexual Behavior Vol. 24, no. 1, 73-93. March 1995.
https://doi.org/10.1007/BF01541990.
4
Miss Major Griffin-Gracy interviewed by AJ Lewis, New York City Trans Oral History Project. Interview Date
December 16, 2017. Transcript #054.
https://s3.amazonaws.com/oral-history/transcripts/NYC+TOHP+Transcript+054+Miss+Major+Griffin-Gracy.pdf.
Accessed April 30, 2019.
3
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as ‘transsexualism’? How did its construction in media foreclose possibilities for certain bodies
to be intelligible as ‘transsexuals’ and access this world of meaning?

Biopower, Problematization, and Medicalization
In order to ground this chapter, I open with Michel Foucault’s concept of medicalization,
which “...describes a process by which nonmedical problems become defined and treated as
medical problems, usually in terms of illnesses or disorders.”5 The concept is typically applied
when to critically analyze a phenomenon which someone is arguing ought not to have been
medicalized, rather than simply stating that something has become medical. Sociologist Peter
Conrad writes that the thrust of medicalization lies in the power of definitions: Medicalization
consists of defining a problem in medical terms, using medical language to describe a problem,
adopting a medical framework to understand a problem, or using a medical intervention to "treat"
it.”6 These definitions, exhibited by diagnostic criteria, symptoms, and treatment options, render
social and bodily phenomenon into pathologies that must be understood and managed through
social control.
Foucault’s concept of ‘biopower,’ the “administration of bodies and the calculated
management of life”7 is best characterized by the “power to qualify, measure, appraise, and
hierarchize”8 on the part of social institutions like medicine. Foucault notes that the key sites of
medical biopower and knowledge are sex, race, and gender, which had to be subjected to

Peter Conrad, “Medicalization and Social Control” in Annual Review of Sociology, Vol. 18, 209-232. Annual
Reviews. 1992. https://www.jstor.org/stable/2083452. 209.
6
Peter Conrad, “Medicalization and Social Control,” 211.
7
Michel Foucault. “Right of Death and Power over Life” in The History of Sexuality, Volume I. Random House.
1978. Available online through http://home.ku.edu.tr/~mbaker/CSHS503/FoucaultHistorySex.pdf. 262.
8
Foucault, “Right of Death and Power over Life,” 266.
5
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biopower in order to maintain production relations under capitalism. He writes on sex, “Power
delineated it, aroused it, and employed it as the proliferating meaning that had always to be
taken control of again lest it escape.”9 Biopower, then, is exercised by all the institutional bodies
and figures that exert social control over gender variance. Its goal is to maintain and manage life,
providing access to medical services only through the mediation and control of medical
professionals, who monitor, scrutinize, and evaluate who is allowed to access transition-related
care and under what conditions.
Trans activist and attorney Dean Spade writes that the medicalization of gender variance,
and thereby the normalization of biological sex and gender, constructs it as an visible social
problem to be controlled and suppressed:10
...medicine produces it [a fiction of natural gender] not through a description of
the norm, but through a generalized account of the norms transgression by gender
deviants. By instructing the doctor/parent/teacher to focus on the transgressive
behavior, the diagnostic criteria for GID11 establishes surveillance and regulation
effective for keeping both non-transsexuals and transsexuals in adherence to their
roles.12
If gender variance were to be understood as a normal social phenomenon consisting of existing
outside, in-between, and/or in opposition to binary sex and gender, the sex/gender system,
supposedly rooted in innate biological differences between ‘men’ and ‘women,’ would be
destabilized. By theorizing gender variance as an inherent pathology, medicalization has
functioned to allow only those who purport to uphold this system to access transition-related
hormonal interventions and surgery, thereby upholding the binary sex/gender system through
maintaining that gender variants are an errant, uncontrollable, medical phenomenon.

9

Foucault. “Right of Death and Power over Life,” 260. Emphasis added.
Dean Spade, “Resisting Medicine, Re/modeling Gender” in Berkeley Women’s Law Journal, Vol. 15, 15-27.
http://www.deanspade.net/wp-content/uploads/2010/07/resisting.pdf. 2003. 25.
11
Gender Identity Disorder.
12
Dean Spade,“Resisting Medicine, Re/modeling Gender,” 25-26.
10
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Dr. Harry Benjamin Invents the Transsexual
Dr. Harry Benjamin (1885-1986) is often canonized13 as the father of transsexualism.14
His pioneering contributions single-handedly shaped much of the contemporary geography of
trans healthcare. Benjamin was a German-American sexologist and endocrinologist, widely
remembered for his groundbreaking work on ‘transsexualism’ between 1948-1979 in the U.S..
He was not the first nor the only doctor15 in the U.S. to provide gender-affirming services to trans
people, however, his work has had a strong impact on mainstreaming and standardizing trans
healthcare and thus deserves substantial attention. Benjamin defied the cultural and medical
norms of his U.S. contemporaries by constructing transness as a medical condition that should be
treated with hormones and surgery, rather than psychotherapy, thereby cracking open a new
world in which some trans people could more readily access the embodiments they desired. At
the same time, other possibilities were foreclosed, such as non-medical and self-determined
conceptions of trans identity that went beyond the white, heteronormative, binary conception.
Perhaps the defining feature of Benjamin’s work was that he advocated providing gender
variant people, or as he called them, ‘transsexuals,’ with hormones and surgery because he
believed that cross-gender identification had somatic causes.16 Benjamin stood out amongst his
American contemporaries for his radical views on sexuality,17 sex, and gender, expressing
“contempt for what he saw as prudery and hypocrisy”18 in American medicine, particularly on

Julian Gill-Peterson. Histories of the Transgender Child. University of Minnesota Press. 2018. 19.
See Schaefer and Wheeler, “Harry Benjamin’s first ten cases,” and Richard Elkins, “Science, Politics, and Clinical
Intervention: Harry Benjamin, Transsexualism, and the Problem of Heteronormativity” in Sexualities Vol 8, Issue 3,
306-328. SAGE. 2005.
15
Joanne Meyerowitz, How Sex Changed: A History of Transsexuality in the United States. Harvard University
Press. 2002. 41-45.
16
Meyerowitz, How Sex Changed, 46.
17
See Meyerowitz, How Sex Changed, 45-46 for more.
18
Meyerowitz, How Sex Changed, 46.
13
14
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the part of psychologists. Benjamin writes about the prudish morality of American doctors and
their taboo19 on providing hormonal and surgical interventions to people who requested them to
alter their appearances:
The forces of nature, however, know nothing of this taboo [the inviolability of
sex/gender], and facts remain facts. Intersexes exist, in body as well as in mind. I
have seen too many transsexual patients to let their picture and their suffering be
obscured by uninformed albeit honest opposition. Furthermore, I felt that after
fifty years in the practice of medicine, and in the evening of life, I need not be too
concerned with a disapproval that touches much more on morals than on science.
20

Many American medical professionals argued against the existence of ‘transsexualism’, arguing
that people who experienced cross-gender identification were experiencing psychotic delusions
that could be remedied through rigorous psychological counseling.21 Take, for example, this
recollection from Christine Jorgensen, a trans woman, who describes an interaction with a
psychiatrist in 1948 after explaining to him that she wanted to ‘be’ a woman: “‘I can’t guarantee
you anything,’ he said. ‘but I’d like you to start a series of psychoanalytic treatments. About
thirty, I would imagine.’”22 Jorgensen continues, “He then explained to me that through these
treatments, he would try to guide me away from these ‘feminine inclinations.’” This
psychiatrist’s reaction was typical of U.S. doctors at midcentury, who did not see hormonal or
surgical intervention as a treatment for this condition. Indeed, historian Joanne Meyerowitz goes
as far to say that “sex-reassignment surgery did not exist” during this period, with a few
exceptions.23
“Any interference with the sacrosanct stability of our sex is one of the great taboos of our time. Therefore, its
violation is strongly resented with emotions likely to run high, even among doctors.” Harry Benjamin, The
Transsexual Phenomenon. The Julian Press. 1966. Available online at
http://www.mut23.de/texte/Harry%20Benjamin%20-%20The%20Transsexual%20Phenomenon.pdf. 9.
20
Benjamin, The Transsexual Phenomenon, 5.
21
U.S. sexologist David O. Cauldwell and sex researcher Alfred Kinsey advocated strongly against surgery as a
‘treatment’ for transsexuality. See Meyerowitz, 44-48.
22
Christine Jorgensen. Christine Jorgensen, A Personal Autobiography. Bantam Books. 1967. 66.
23
Meyerowitz, How Sex Changed, 49.
19
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Between 1938-1953, Benjamin, in his sixties, saw the first ten ‘transsexual’ patients of
his career, who came to him when no such formal diagnosis existed.24 Historian Joanne
Meyerowitz reminds us, “They did not need the label ‘transsexual’ or ‘transgender’ to articulate
a request to change sex. They tried to identify their problem with whatever labels they had, and
then they asked for help.”25 For these first patients, Benjamin simultaneously functioned as an
endocrinologist, counselor, reference for plastic surgeons, and helped link transgender people
with others like them.26 Richard Elkins notes that this period of Benjamin’s work “...predates the
period of a sophisticated terminology of sex, sexuality and gender. There is no language of
gender identity or gender dysphoria for Benjamin to draw on.”27 By creating his own terms,
definitions, diagnostic criteria, and treatments, Benjamin assumed a massive amount of medical
authority and took the first steps to medicalize gender variance as a condition known as
‘transsexualism.’ Benjamin would later write in 1966, “There is a challenge as well as a
handicap in writing a book on a subject that is not yet covered in the medical literature.
Transsexualism is such a subject.”28 Embedded within this statement is Benjamin’s
presupposition that ‘transsexualism’ was, in fact, a medical problem that needed to be covered in
medical discourse, and that he was the one qualified to take the first steps to make this happen.

Constructing the Symptoms

Schaefer and Wheeler, “Harry Benjamin’s first ten cases”.
Meyerowitz, How Sex Changed, 36.
26
Schaefer and Wheeler, “Harry Benjamin’s first ten cases”.
27
Richard Elkins, “Science, Politics, and Clinical Intervention: Harry Benjamin, Transsexualism and the Problem of
Heteronormativity” in Sexualities Vol. 8, no. 3, pp. 306-328. 2005.
28
Benjamin, The Transsexual Phenomenon, 4.
24
25
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Benjamin’s construction of transsexuality as a medical problem rested on defining its
symptoms. Although the term “transsexual” had been in use since in the U.S. since at least 1949
when Dr. David O. Cauldwell wrote “Psychopathia Transsexualis,” Benjamin popularized the
term “transsexual” in the early 1950s.29 Many of his early patients30 described experiencing
gender-confusion early in life,31 distress about their bodies 32 characterized by a desire to be rid
of them, and an inability to function in society the way that ‘normal’ people did.33 Benjamin,
upon hearing this information, decided that these would constitute the symptoms of ‘true’
transsexuality, a concept he first invoked through differentiating between the three different
‘types’ of transsexuals, 1, 2, and 3, with 3 showing the highest “degree of sex and gender role
confusion,” and a “much deeper emotional disturbance.” Benjamin writes, “He lives only for the
day when his "female soul" is no longer being outraged by his male body, when he can function
as a female - socially, legally, and sexually.”34 He also considered this group to be largely
asexual: “...he is often asexual or masturbates on occasion, imagining himself to be female.”35 It
was this group that Benjamin advocated treating with hormone therapy and surgical intervention.
In 1949, Benjamin met his first “true”36 transsexual patient, Val Barry, a 23-year-old
patient referred to him by sex researcher Alfred Kinsey, who met Barry while taking sex
Susan Stryker, Transgender History, 3 8.
 It is important to note that 8/9 patients were male-to-female, while only one was female-to-male; all were
socioeconomically middle-class (3 were raised in upper-class backgrounds); 9 received hormonal therapy, with 6
undergoing genital surgery. No information about the racial/ethnic makeup of this group was provided. Schaefer and
Wheeler, “Harry Benjamin’s first ten cases”.
31
 See Benjamin, The Transsexual Phenomenon, 37, and Schaefer and Wheeler, “Harry Benjamin’s first ten cases”,
73.
32
“The transsexual (TS) male or female is deeply unhappy as a member of the sex (or gender) to which he or she
was assigned by the anatomical structure of the body, particularly the genitals…their sex organs, the primary (testes)
as well as the secondary (penis and others) are disgusting deformities that must be changed by the surgeon’s knife.”
Benjamin, The Transsexual Phenomenon, 11.
33
Schaefer and Wheeler, “Harry Benjamin’s first ten cases”.
34
Benjamin, The Transsexual Phenomenon, 13-14.
35
Ibid.
36
Schaefer and Wheeler, “Harry Benjamin’s first ten cases”, 76.
29
30
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histories in San Francisco in 1948.37 Barry was desperately seeking feminizing hormones and
surgery to alter her body. Benjamin could provide estrogen therapy, not surgery; but he urged her
to pursue it in Europe. Benjamin inquired38 of California’s district attorney, Edmund G. Brown,
about the legality of castration in the state, to which Brown replied the procedure would
constitute a violation of so-called “mayhem statues,” laws dating back to English common law in
the middle ages which criminalized the willful disabling or destruction of the healthy tissue of
another person.39 Psychiatrist Karl Bowman and sex researcher Alfred Kinsey decided not to
endorse surgery for Barry, opined that surgery would not cure Barry’s psychological condition.
Benjamin continued to assist Barry, eventually helping her to find a doctor willing to do her
genital surgery in Sweden in 1953.40
Interesting in regards to Barry’s story is how she is described as a ‘true transsexual’.41
Schaefer and Wheeler write retrospectively about Barry, emphasizing that she dressed as a girl
consistently in her early childhood, even while at school. Reviewing her institutional records,
they write that she had a "desire from childhood to be a girl and from puberty to change
physically”, so that she "could marry, have a house and children.”42 Her desire to alter her
embodiment to align more with a ‘female’ body, then, seemed to stem from a pathology that took
hold early in her life, and was also bolstered by her aspirations to become a housewife. The
consistency of her gender expression and identification is further taken by Schaefer and Wheeler
as evidence of symptoms characteristic of ‘transsexuals.’ Barry’s "ideas, interests, and modes of

37

38

Schaefer and Wheeler.

“Annoyed, Benjamin replied: ‘it is difficult to reconcile my common sense with the fact that statutes based on the

requirements of English kings in the middle ages should still be valid…’” Meyerowitz, How Sex Changed, 4 7.
39
Stryker, Transgender History, 62.
40
Meyerowitz, How Sex Changed, 48.
41
Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 76.
42
Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 77.
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thought were consistently feminine,” and she "denied ever having an erection (nocturnal or
otherwise) and...ever masturbating.”43 Benjamin’s idea of the true transsexual as assexual and in
a pure state devoid of sexuality creates a subject stripped of eroticism and desire, unable to
experience sexuality lest they be seen as homosexual or not truly experiencing a desire to be of
another gender. Possibilities for expressing sexuality pre-transition was threatening to the idea
that gender preceded sexuality, a common idea in the post-war United States.44
Benjamin’s idea of the ‘true transsexual’ was predicated on the ability and desire of the
person to ‘pass’ as a person with binary gender. Miss Major, a black trans woman and trans
rights activist who was born in 1942, recounted her life as a street queen during the late 1950s in
Chicago over the course of an interview with trans historian Susan Stryker. Major obtained her
hormones through the black market, paying an unnamed private doctor on the North side of
Chicago $25 per shot of estrogen with money she earned through hooking.45 When she moved to
New York City in 1960, she tried to get hormones from Benjamin to no avail. She recounted the
experience in an interview with the New York City Trans Oral History Project:
Girl, we tried, child, we tried. We went there and the receptionist was very polite
and very sweet but very no. [laughs] Yeah, “he’s not seeing you”. And at the
time, any girl that went to him, you had to go to him “done”. You couldn’t go to
him in boy’s clothes because you were out running around during the day time.
You had to be “done”. You had to be dressed. You had to have your shit together.
So that means you got dressed at home, you jumped in a cab, cause you couldn’t
go anywhere in public, we couldn’t take that chance. Directly to his office. Have
the cab stop in front, run inside, have the cab meet you when you went to leave
and then go home.46
Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 77.
Michael David Franklin, “Calculating Risk History of Medicine, Transgender Oral History, and the Institutional
Review Board” in Queer Twin Cities. Twin Cities GLBT History Project. University of Minnesota Press. 2010. 30.
45
Miss Major interviewed by Susan Stryker. GLBT Historical Society. Interview Date January 29,
1998.http://docs.glbthistory.org/oh/Major1-29-1988_web.pdf. Accessed April 25, 2019.
46
Miss Major Griffin-Gracy interviewed by AJ Lewis. New York City Trans Oral History Project. Interview
Transcript #054. December 16, 2017.
https://s3.amazonaws.com/oral-history/transcripts/NYC+TOHP+Transcript+054+Miss+Major+Griffin-Gracy.pdf.
Accessed April 26, 2019.
43
44
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‘True transsexuals,’ it seemed, had to perform gender to such an extent that they put their safety47
in jeopardy in order to meet the medical criteria for a diagnosis. For many trans people, this was
not possible in day-to-day life. It is apparent from Major’s statement that Benjamin thought of
the ability to successfully pass as the desired gender as a prerequisite for undergoing hormone
therapy and possible surgical interventions. People he thought could pass not was not allowed to
access hormones through a legitimate medical venue. In the 1963 edition of Sexology magazine,
an anonymous trans person wrote to Benjamin asking about what they could do to “end” their
“misery.”48 In order to determine if a ‘sex change’ was appropriate to recommend, one of his
questions in response was,
Is your general appearance and physical build such that you can pass as a woman,
or is it possible you will look more like a man dressed up as a woman? Don’t ask
the mirror, take the word of an objective outsider.49
By this logic, a major consideration in a person’s decision to pursue transitioning had to be the
viability of ‘success’ in the desired gender. However, the agency of the trans person to decide
this for themself is displaced by the word of the “objective outsider,” who must determine if they
could, in fact, pass. The sentiment that trans people are not ‘objective enough’ to determine
whether they are trans or pass as their desired gender is strange, especially since there still to this
day has been no successful diagnostic test that can conclusively determine if someone is

Many trans people do not sufficiently ‘pass’ prior to undergoing hormonal and surgical interventions, thereby
exposing them to social control and discipline for their gender transgressions in the form of extra legal (and legal)
violence from strangers and law enforcement. This kind of violence did not fall on trans people indiscriminately;
when asked about encounters with law enforcement and institutionalization, Miss Major replied:
“...It happened to..well, not exactly ALL of us…there were a few that skated through, come from, you know money.
So they do a lot, they do better than the rest of us. They actually get to be an older person without a record, or
fingerprints or abuse from the police.” Miss Major Griffin-Gracy interviewed by AJ Lewis. New York City Trans
Oral History Project.
48
Harry Benjamin, “I Want to Change My Sex!” in Sexology: Modern Guide to Sex Knowledge. Gernsback.
December 1963. 292.
49
Harry Benjamin, “I Want to Change My Sex!,” 293-294.
47
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transgender. Medical authority, then, is positioned as the objective outside eye that can discern
the appropriateness of transition for trans people.
Intrinsic to the success of medicalization is upholding the fiction that doctors and experts
are objective outsiders that are immune from subjective thoughts, biases, and emotions. It is
obvious, however, that Benjamin’s medical ‘objectivity’ was not such. Miss Major reflects on
her impression of Benjamin:
Personally, he only did girls he thought would pass. He only did white girls. He
only did girls who were between, no one taller than 5’6’’. Would help those girls.
So taller girls like myself had to find other places. The black girls had to go to
other places. Stuff like that.50
Major’s remarks beg the question: why did the doctor withhold treatment from black trans
people who went to his office? Why did he not consider that these people were worthy of his
medical care and attention? Trans historian Julian Gill-Peterson writes, “...the abstract whiteness
projected onto the white trans body justified the attention given by doctors. Black trans and trans
of color patients were much rarer because they were by design not welcome within that
discourse.”51 The medical discourse created by Benjamin about transness had little space to
accommodate the ‘treatment’ of Black trans people. Benjamin made choices, rooted in racism,
about who was to be given access to a transition under the supervision of professionals. He made
value judgments on the worthiness of Black trans people to receive medical attention.
His decisions to deny access to hormone therapy and referrals for surgery had material
effects on Black trans people’s lives and created no legitimate path for them to materialize the
embodiment they desired. They were not going to stop pursuing hormone therapy, as evidenced
by Miss Majors words ‘...the black girls had to find other places.’52 They looked to the black
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market53 to self-administer the care that the medical profession was unwilling to provide to them,
thereby creating an alternate means of materializing their desired embodiment outside of the
dominant medical framework. In being forced to resort to obtain hormones outside of legitimate
medical avenues, Black trans people were disenfranchised from accessing medical recognition as
transsexual and subsequent understanding as such. The possibility that Black people were, in
fact, trans at all was withheld by the medical model. Gill-Peterson writes, “...the whiteness of
medicine interfere[s] with the intelligibility and livelihood of black, brown, indigenous, and
other marginal trans people…”54 Intelligibility, on the one hand, is a function of medicalization,
and its ability to make understandable and categorizable aids in the social control and discipline
of trans people. On the other hand, it also facilitates access to a certain level of safety in pursuing
a medical transition. Self-administering very strong drugs that need to be carefully monitored in
the blood in order to ensure that damage is not done to organs such as the liver and heart is not
optimal in terms of maintaining a healthy life, especially at a time when so little was known
about them. Ceyenne Doroshow, a Black trans woman who lived in New York City in the early
1970s, recounts the story of her role model, an older Black trans woman, who showed her how to
inject estrogen and gave her her first dose.55 This role model, who had been taking hormones
illegally for 30 years, died due to organ failure that was caused by unmonitored use of high doses
of estrogen.56 Black trans people were thus left to navigate the uncertainty of the black market
for hormones and surgical interventions.
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The idea of ‘true’ transsexuality conferred a belief that the narratives Benjamin’s patients
presented stemmed from real lived experience rather than a selective and highly performative
re-reading of past events in one’s life. Schaefer and Wheeler write,
Even without any books to read, without any other source of information, with or
without childhood conditioning, with or without dystonic families, assuming that
he or she was alone and unlike anyone else in the world, Benjamin's earliest
patients came to him self-diagnosed, in that they described symptoms and
conditions exactly as his patients continued to describe themselves throughout his
30-year practice; and exactly as we continue to hear them describe themselves.57
This assumes that Benjamin’s first patients exhibited some fundamental truth about the nature of
transness. They completely overlook the fact that trans people had access to information, albeit
limited, about their ‘condition’. Many read works published about transness and emulated the
narratives and information that they found contained within58 when talking to others, particularly
to medical professionals. In the next section, I will turn to a discussion about narratives and
tropes surrounding trans identity in popular culture during mid-century.

Christine Jorgensen, Trans Normativity, and ‘Leaving it to the Experts’
At the same time that medicalized trans identity was being formulated, the media
circulation of Christine Jorgensen’s story brought ‘transsexuality’ to the attention of the larger
U.S. public for the first time.59 Jorgensen, a white trans woman, underwent hormone therapy and
a series of genital surgeries during the early 1950s in Denmark under the supervision of Danish
endocrinologist Dr. Christian Hamburger. She attracted a storm of mainstream media attention
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beginning in 1952 when she the story of her ‘sex change’ was leaked to the press,60 and
maintained it well into the early 1970s.61 Jorgensen’s story popularly introduced the idea in the
U.S. of a non-psychological treatment path for the problem of transsexuality.62 Jorgensen’s
whiteness, in conjunction with her hypervisibility in media, contributed to solidifying
transsexualism as something that could only be intelligible when it was exhibited through
whiteness. As historian Joanne Meyerowitz writes, Jorgensen was hyper-feminine, heterosexual,
and blonde, “the hallmark of 1950s white feminine glamour.”63 As her image circulated around
the world, in arguably the first instance of a trans person that was this highly publicized, people
came to associate achieving "convincing and conventional”64 white femininity with a successful
transition.65 Thus, a successful medical transition was characterized by achieving and ever
striving towards normative white femininity. Feminist theorist Emily Skidmore writes, “...white
transwomen were able to articulate transsexuality as an acceptable subject position through an
embodiment of the norms of white womanhood, most notably domesticity, respectability, and
heterosexuality.”66 In other words, key to the process of establishing someone as an intelligible
‘transsexual’ was to construct them, apart from the fact of their transsexuality, as just like
‘everyone else.’ To aspire to white feminine ideals (for trans women) was to aspire to achieve
medicalized transsexual subjectivity, rendered socially acceptable and respectable by merit of its
proximity to whiteness.
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For Jorgensen, creating the trans story involved a process of creating negative space
against which to define herself. Jorgensen’s memoir, Christine Jorgensen: A Personal
Autobiography p ublished in 1967, distances herself from queerness. Any suspicions the reader
might have that she had queer desires were thwarted in her memoir, which is very explicit that
she was straight. She writes,
During the months in service, I had seen a few practicing homosexuals, those
whom the other men called ‘queer.’ I couldn’t condemn them, but I also knew that
I certainly couldn’t become like them…67
Faced with accusations that she was actually a gay man or a drag queen from the mainstream
press, Jorgensen worked tirelessly to distance herself from queerness, and reassert again and
again that she was not queer. I am not doubting the veracity of her sexuality; I am merely trying
to point out that she contrasted herself, the ‘good’ transsexual, with the other, bad trannies and
queers who violated social and sexual taboos. In her memoir, she recounts “with shock and
disgust”68 a man who made an unwanted advance on her before her transition, and writes, rather
dramatically, “I spun away from his lumbering figure and pushed blindly through the crowd of
young people into the darkness outside, heading for the beach…I leaned over the edge of the pier
and vomited.”69 While part of her reaction certainly had to do with the feeling of being subjected
to an unwelcome flirtation, the severity of the disgust she describes is mostly related to the fact
that it was a queer encounter. She tries to explain away the encounter with an appeal to the
innateness of her femininity, wondering, “Was it my slight build, my blonde complexion? But
what did bone-structure have to do with it? …there had to be some physical explanation for my
difficulty.”70 In so doing, she constructs herself as heterosexual and reifies her white femininity,
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in a way intentioned to gain sympathy from mainstream heteronormative society and assert that
trans people were not homosexual.
Christine’s story of pursuing “life and the freedom to live it,”71 in other words, the ability
to be understood as transsexual so that she could access her desired embodiment, can be directly
contrasted with the construction of black trans people’s lives during this time period. Indeed,
Jorgensen’s narrative and public persona carefully contrasted her respectability against social
deviants who deserved moral condemnation.72 Black trans historian C. Riley Snorton’s book
Black on Both Sides tells the stories of black trans people whose stories emerged during the same
time as Jorgensen’s, but largely remained confined to the black press. Snorton writes that telling
these narratives does not simply ‘add’ the stories of Black trans people at mid-century, but
“disrupt[s] the teleology of medicalized transsexuality as corporeal freedom.”73 Carlett Brown, a
Black trans woman whose story emerged in the Black press in 1953, was characterized as a
‘mimicker’ of Jorgensen by the press.74 Brown’s life as a shake dancer, a stigmatized occupation,
was not welcome or accommodated for within the medical trans identity. She pursued a medical
transition in Europe, but her plans were ultimately stunted by the federal government, which
forbade her to leave the U.S. until she paid a $1,200 federal income tax debt. Regardless of if she
actually underwent such a surgery, Brown and other Black trans women faced police harassment
on a daily basis.75 Thus, Snoton writes, “…Jorgensen’s spectacularized transsexual ‘freedom’
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was tethered to equally robust representations of radicalized unfreedom…”76 Many Black trans
women were not intelligible as feminine or as real women in the way that Jorgensen was,
because of their categorical distance from normative white femininity, and were thus left to be
disciplined and controlled by law enforcement and errant violence alongside the freaks and
anomalies that Jorgensen sought to distance herself from.
Subjective experiences of trans identity at mid-century were not entirely tethered to the
medical model; many people lived tangible and satisfying lives in non-assigned genders in ways
that did not depend on the clinic. Take, for example, Ava Betty Brown, a black trans woman
whose story emerged in a 1957 edition of black newspaper The Chicago Defender after she was
arrested for wearing women’s clothes. While she was being tried, she defended her identity as a
woman by asserting that everyone in her life knew her as such. She said, “Everything I own is in
the name of Betty Brown…If I am a man, I don’t know it.”77 While the paradigm of transexuality
as an exclusively medical phenomenon ascended, Black trans people did, in fact, assert a claim
to a trans existence by using “an alternative set of relations--that of black sociality--as the site for
her gender articulation…”78 As evidenced by an article published 12 years later detailing an
arrest--again for crossdressing--revealed that police violence and harassment still animated
Brown’s day-to-day life. Her plans to obtain surgery in Denmark were “indefinitely deferred.”79
Thus, her claim to trans identity would remain in the social fabric of black life, never recognized
as trans by the broader public or the medical establishment.
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Jorgensen’s narrative helped reinforce the notion that transness was in fact a medical
condition, the understanding of which should be left up to medical professionals and experts. In
her memoir, she affectionately refers to the doctors she associated with, even going so far as to
change her name to Christine, the feminine iteration of Christian, the first name of her
endocrinologist in Denmark, Dr. Hamburger.80 After her final surgery, she writes, “I felt at last
that I’d completed the transition to womanhood, and except for the inability to bear children, was
as complete a person as I’d dreamed of being, both emotionally and physiologically.”81 Only
once her genital surgery was ‘complete’ did she feel that she was a true woman, implying that
the only way for trans people to achieve their desired gender identity was to undergo a
‘complete’ surgical and hormonal transformation. She concludes her memoir on a positive note,
remarking on the opening of the first gender identity clinic at Johns Hopkins University in 1966
and the steady progress of medicine in relation to ‘transsexualism’. In a move to completely
surrender her autonomous knowledge about her identity, she writes, “This book, then, is not
meant to be a history of transsexualism or a study of its medical management. I leave that to the
experts.”82 In the following section, I turn to the university-based gender identity clinics as a site
for the construction of gender.
The Gender Identity Clinic as a Site for the Construction of (trans)Gender
Gender identity clinics adopted the medicalized model of transness, which
institutionalized the standards, diagnostic criteria and treatments on a national scale, laying the
groundwork for the professionalization of trans healthcare as a legitimate medical field. Between
the late 1960s and the early 1970s, several university-based gender identity clinics cropped up
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around the U.S., and used Benjamins’ 1966 book The Transsexual Phenomenon as “their
standard reference”.83 The Johns Hopkins University Gender Identity Clinic opened in 1966,
making it the first hospital in the United States to surgically treat ‘transsexuals’ through gender
affirmation surgeries, including bottom surgery.84 The team consisted of plastic surgeons,
psychologists, psychiatrists, urologists, gynecologists, and one pediatrician.85 Reed Erickson, a
transgender man and millionaire philanthropist, provided substantial funding to the gender
identity clinics.86 Gender identity clinics substantially increased the mainstream availability of
hormones and surgery in the U.S. and provided a legitimizing force for the professionals who
provided such treatments for transness. The primary goal of such clinics, according to the head
plastic surgeon of the clinic at Johns Hopkins, Dr. John Hoopes, was finding “a sound means of
alleviating the problem of gender identification and of fostering public understanding of these
extremely unfortunate individuals.”87 This ultimately culminated in the production of a
standardized medical model for treating transsexualism.88
Gender identity clinics engaged in a project of “grafting intelligibility onto the
transsexual”89 as a distinct medical disorder that could be treated only through hormone therapy
and surgical interventions intentioned to render the trans person as passing as possible. Part of
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this process involved developing objective criteria beyond Benjamin’s that could reliably
‘diagnose’ transsexualism. Trans author and activist Sandy Stone argues that these criteria
functioned to actually produce gendered subjects, writing “The criteria constituted a fully
acculturated, consensual definition of gender, and at the site of their enactment we can locate an
actual instance of the apparatus of the production of gender. ”90 Of roughly 2000 applications
received in the first two years that the Johns Hopkins clinic was open, only 24 were able to meet
the criteria developed by these clinics.91 After getting on a waiting list (the clinic only accepted 2
patients per month), trans people had to undergo extensive psychological and physical
examinations, as required by the clinic, prior to receiving any kind of care.92 “Only those who
show no signs of psychosis and appear to have a degree of insight into their condition are
accepted…”93 Patients were required to exhibit gender dysphoria at an early age, be attracted to
the “same biological sex,” have tried and failed to live in their assigned sex, be able to “pass”
successfully if treatment is administered, and undergo a ‘real-life test’ of one year living as the
desired gender.94 Patients were expected to remain “heterosexual” after their gender-affirming
surgery was completed, and eventually marry.95 Dana Beyer, a trans activist who went to the
Hopkins clinic in the 70s, remarked: “No one said this explicitly, but they certainly implied it,
that the whole purpose of this was to get a vagina so you could be penetrated by a penis.”96
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Through creating criteria and conditions for treatment, the gender identity clinics defined further
that ‘transsexualism’ was a label that would only be given to those who cooperated with
medicine to reproduce normative gender in otherwise gender deviant persons.
This highly selective process, rather than having the result of successfully ‘diagnosing’
transness, facilitated the exercise of medical control and regulation over the socially contentious
force that was transness. Trans historian Michael David Franklin writes that the clinics careful
production of transsexual subjects was intentioned to “...discipline the nonconformity that
galvanized political ferment and to diagnose the insurgencies that convulsed the nation and
undermined authority.”97 Indeed, by constructing what counted as legitimately trans, these clinics
also constructed what did not constitute a trans subject along the lines of race, class, nationality,
and sexualty. Trans historian Julian Gill-Peterson critiques the gender identity clinics, writing,
The overwhelming majority of trans patients seen at institutions of medicine were
white. Even in the most pathologizing and disenfranchising medical models, the
abstract whiteness projected onto the white trans body justified the attention given
by doctors. Black trans and trans of color patients were much rarer because they
were by design not welcome within that discourse.98
The Black and trans of color people who were excluded from treatment at Johns Hopkins and
other gender identity clinics were denied access to the medical trans identity because they did not
aid in its project of producing successful patients who would uphold the normative gender,
sexuality, and whiteness. Good transsexuals would ultimately become productive citizens who
contributed to society through respectable lives that involved legal employment,99 marriage, and
social intelligibility.
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The ultimate goal in the treatment of transsexualism was to produce subjects that were
visually and socially legible in their binary gender of choice. Sandy Stone, discussing the gender
identity clinic at Stanford, writes that staff selected candidates for surgery based on an
“individual sense” of the suitability of each patient for passing as their desired gender.100 She
quotes Dr. Norman Fisk, head of the clinic as saying, “I now admit very candidly that...in the
early phases we were avowedly seeking candidates who would have the best chance for
success. ”101 Rather than the goal being a successful, meaning without complications, surgery,
success is defined in terms of achieving passing status on the part of the trans person. This
particular clinic functioned as a “charm school” in that it sought to teach patients how to “behave
like” women, “...i.e. gendered females.”102 Indeed, these clinics understood very well that gender
was, in fact, learned. Harry Benjamin, responding to an anonymous trans person seeking medical
intervention in 1963, gave the following advice on passing:
When you have recovered from the pain and the after-effects of the operation,
after a few weeks or months, your real work begins—to change into a ‘woman.’
You have to learn how to behave like a woman, how to walk, how to use your
hands, how to talk, how to apply make-up and how to dress.103
Defining success in terms of passing profoundly restricted the possibilities for trans people who
could not or did not want to pass to access medical services under the newly emerging
professional model of treatment.
The obstacles set up by the gender identity clinics were put in place with the intention of
only providing access to those trans people who fit their criteria. Some trans people, however,
found creative ways of getting around this model and achieving the embodiment they desired.
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Joanne Meyerowitz illustrates that some trans women in the late 1960s, who had adopted a
“casual, unisex, hippie style”104 advised each other on how to get around the system.
...their transsexual friends told them they had to dress up as conventionally
feminine women…[t]hey also warned one another to refrain from mentioning
certain details about their sex lives, especially if they took pleasure from their
genitals or intended to live as homosexuals after their surgery.105
Many of the researchers who kept hearing the same stories and seeing the same types of people
over and over again, “whose behavior matched up gratifyingly with Benjamin’s criteria,”106 took
this to mean that they had finally discovered some inherent truth about transsexuality. Trans
people, simply wanting to access hormones and surgery, sought to get around this system, telling
the researchers exactly what they wanted to hear. Stone writes that this cyclical pattern “seems a
recipe for an uneasy adversarial relationship”107 between trans people and medical professionals.
This relationship remains uneasy to this day.
Gender identity clinics were closed down following the 1979 publication of a much
discredited study108 by Dr. Jon K. Meyer and Donna J. Reter of Johns Hopkins that concluded
trans people who received surgical interventions were not more well adjusted to life
postoperatively as compared to transgender people who did not receive surgery. Dr. Meyer was a
psychologist that maintained the belief that the phenomenon of transness was an inherently
psychological problem that could not be solved through hormonal or surgical therapies. Meyer
told the New York Times in 1979, “My personal feeling is that surgery is not proper treatment for
a psychiatric disorder, and it’s clear to me that these patients have severe psychological problems
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that don’t go away following surgery.”109 The study measured adjustment through the post-op
trans person’s adherence to a heteronormative livestyle following surgery. The researchers
assigned each subject a score in order to measure their adjustment; things that earned positive
points were improvements in job level and heterosexual marriage/cohabitation, while arrests, jail
sentences, decline in job level, psychiatric treatment, and “nongender appropriate cohabitation or
marriage.”110 Meyer’s study reinforced the notion that the goal of treating trans people was to
produce productive subjects that aligned with normative gender, sexuality, middle-class values,
and whiteness. The study, though it was widely criticized by doctors and researchers alike,
however, this study was all that was needed to topple the gender identity clinic system that had
emerged only 13 years earlier.
In the next chapter, I turn to the emergence of professional associations that implemented
a standardized model for the medical management of transness following the closure of gender
identity clinics.
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Chapter 2
Gatekeeping Trans Healthcare: Passing the Diagnostic Test/Passing in the Streets
“How do you know you want rhinoplasty, a nose job?” he inquires, fixing me
with a penetrating stare.
“Because,” I reply, suddenly unable to raise my eyes above his brown wingtips,
“I’ve always felt like a small-nosed woman trapped in a large-nosed body.”
“And how long have you felt this way?” He leans forward, sounding as if he
knows the answer and needs only to hear the words.
“Oh, since I was five or six, doctor, practically all my life.”
“Then you have rhino-identity disorder,” the shoetops state flatly. My body sags
in relief. “But first,” he goes on, “we want you to get letters from two
psychiatrists and live as a small-nosed woman for three years . . . just to be sure.”
111

Introduction
The standardization of trans healthcare that took place between the 1980s and the current
moment institutionalized and refined the model of care developed by Harry Benjamin and his
associates at the university-based gender identity clinics. Now referred to as the gatekeeping
model, it functions to sort those who meet the diagnostic criteria from those who do not, thereby
regulating access to transition-related healthcare. What are the politics of installing a gatekeeping
mechanism in the form of a mental health professional? How is gender dysphoria diagnosed?
How can we balance maintaining access to care within a pathological framework? What modes
of existence are allowed to be considered diagnosably trans? Why are authentic narratives of the
self illegitimate under this model? I argue that the gatekeeping model is aimed at controlling,
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disciplining, and regulating the expression of gender variance and restricting trans people’s
ability to access the embodiment they desire under the care of a medical professional.

Standardizing Trans Medicine in the Private Sphere
With the closure of gender identity clinics in 1979, the medical management of trans
people largely relocated to the sphere of private practices. In 1978, medical professionals who
worked in the budding field of trans healthcare established the Harry Benjamin International
Gender Dysphoria Association (HBIGDA).112 HBIGDA released the first professional guidelines
on treating ‘transsexuals’ in 1979, the same year that the clinics began closing. The Standards of
Care (SOC) were created in order to standardize the medical treatment provided by professionals
at private practices,113 who were now expected to follow the “minimal requirements”114 outlined
in the standards. While these standards were not legally binding, they established that uniform
professional standards in the treatment of ‘transsexuals’ were necessary to provide appropriate
‘care’. By creating this document, the HBIGDA constructed itself as the leading medical
authority on transness and the sole professional group authorized to determine how treatment
was to be rationed.
By adopting the psychiatric diagnosis “transsexualism” from the 1980 DSM-III, the SOC
solidified that there was to be a regulatory mechanism, a gatekeeper, that rationed out the
‘treatment’ in a way that reinforced medicalized transness and binary gender. The original SOC
required people who sought ‘sex reassignment’ to acquire multiple recommendations from
clinical behavioral scientists with extensive credentials in order to access hormones and surgery.
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These mental health professionals were to be gatekeepers, tasked with sorting, classifying, and

diagnosing transsexualism in suitable candidates. The decision to write a recommendation letter
largely centered around how well a person matched the DSM-III diagnosis for ‘transsexualism,’
which outlined the diagnostic criteria as follows: experiencing a “sense of discomfort...about
one’s anatomic sex,” a “wish to be rid of one’s own genitals and live as a member of the other
sex,” “the disturbance has been continuous...for at least two years,” and is exhibited in the
“absence of physical intersex or genetic abnormality, and is “not due to another mental disorder,
such as schizophrenia.”116 Whether or not a person met these criteria was to be established during
a therapeutic relationship, which needed to last “at least three months”117 prior to starting
hormone therapy and “at least six months”118 prior to genital/breast surgery. Surgical access was
to be more heavily regulated; in addition to at least 6 months of counseling prior to making a
diagnosis and recommendation, the initial decision to allow access to surgery was to be subject
to “peer review” by another independent clinical behavioral scientist.119 Clearly, the authors of
the SOC felt that it was important to have several roadblocks in place, in particular emphasizing
time and careful professional decision-making when selecting an appropriate candidate to
receive treatment.
The SOC were especially concerned with guarding against ‘hormones on demand,’ or
access to ‘treatment’ on the transsexual’s terms, which was to be avoided at all costs. The third
version of the Standards, published in 1980, read, “[h]ormonal and surgical sex reassignment are
procedures requiring justification and are not of such minor consequence as to be performed on
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an elective basis.”120 By emphasizing that trans people do not have the capacity to make
important decisions about their bodies and lives, the gatekeeping model sought to ensure that
each candidate was scrutinized as thoroughly as possible in order to prevent trans people from
making a rash or misguided decision. The first standard in the original SOC reads as follows:
Hormonal and/or surgical sex reassignment on demand (i.e., justified simply
because the patient has requested such procedures) is contraindicated.121 It is
herein declared to be professionally improper to conduct, offer, administer or
perform hormonal sex reassignment and/or surgical sex without careful evaluation
of the patient’s reasons for requesting such services and evaluation of the beliefs
and attitudes upon which such reasons are based.122
Medicalizing trans identity as a disorder was predicated upon solidifying the notion that it could
not be understood or diagnosed by lay-people: professionals had to maintain authority over the
power to diagnose. Speech act theory posits that words are capable of doing things or bringing
things into reality: for example, when a justice of the peace says, “I now pronounce you husband
and wife,” those two people are now married by virtue of that statement. The positionality of the
speaker matters because only words that come from certain mouths have the power to
accomplish certain acts. To diagnose oneself is an oxymoron: it is simply not possible to
diagnose yourself because diagnosis is only made possible through the removal of autonomous
sources of knowledge about the self. By establishing a gatekeeping mechanism, trans people
were rendered unable to perform the ‘speech act’ of declaring themselves trans in any
meaningful sense within a medical context. Allowing trans people to simply request and receive
the medical procedures they desired would allow those whose very existence threatened the
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binary to pass through, threatening the very stability of the medicalized framework that was built
to control and discipline deviant gender expression.
The early SOC included a standard that required individuals seeking ‘sex reassignment’
to undergo a ‘real-life test’ by living full-time in the gender of choice. It reads, “Genital sex
reassignment shall be preceded by a period of at least 12 months during which time the patient
lives full-time in the social role of the genetically other sex.”123 This assumes that only once the
trans person has consulted with a therapist will they actually begin navigating the world
‘full-time’ as another gender. Not only does this preclude possibilities for expressions of gender
deviance outside of the medical framework, it also reifies binary gender by implying that the
person must have a consistently binary gender expression at all times for a full year.
Additionally, there are many factors that would make it difficult for people to live “full-time” as
another gender other than the legitimacy of their transness, namely: employment discrimination,
familial relationships, violence on the street upon being clocked, or simply not wanting to do that
because their gender expression was fluid.
Professional medical associations other than HBIGDA also participated standardizing the
diagnosis and treatment of transness. The American Psychiatric Association (APA) developed its
first diagnostic criteria for ‘transsexualism’ in 1980. The DSM, the diagnostic manual produced
the APA, is the authoritative text used by medical professionals to diagnose and treat mental and
behavioral health disorders. The DSM-III, published in 1980, included the diagnosis
‘transsexualism’ and categorized it under psychosexual disorders.124 By 1994, the DSM shifted
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to using the diagnosis ‘gender identity disorder.’125 The most recent version, the DSM-5, was
published in 2013 with the updated diagnosis of “gender dysphoria.”126 Looking in the table of
contents for the DSM-5, nestled under a whole host of diagnostic terms for mental disorders such
as “Obsessive Compulsive and Related Disorders” and “Dissociative Disorders,” lies “Gender
Dysphoria” as its own category of disorder.127 In order to activate access to gender-related
hormones and/or surgery, people seeking these procedures must often obtain a diagnosis for
gender dysphoria from a qualified mental health professional. They describe gender dysphoria
as, “...the distress that may accompany the incongruence between one’s experienced or expressed
gender and one’s assigned gender...many are distressed if the desired physical interventions by
means of hormones and/ or surgery are not available.”128 In the diagnostic features for
adolescents and adults, which is separate from the ones for children,129 it reads that the “core
component” of gender dysphoria is experiencing a “marked incongruence” between the gender
assigned at birth and the person’s “experienced/expressed gender.”130 This incongruence is
marked by a “strong desire to be rid of one’s primary and/or secondary sex characteristics” and a
“strong desire for the primary and/or secondary sex characteristics of the other gender.”131
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While the DSM-5 was being written, the APA created the DSM-5 Work-group on Sexual
and Gender Identity Disorders to deal with the contested diagnosis of gender identity disorder.
LGBTQ activists demanded that the APA eliminate all gender diagnoses on the grounds that they
were pathologizing and subjected trans people to unnecessary stigma.132 The work-group, on the
other hand, was concerned that this would reduce access to care because health insurance
providers refuse to reimburse for treatment without a diagnosis. One of the people in the
work-group, Jack Drescher, reflects on the deliberation process:
In an effort to balance these conflicting concerns between stigma and access to
care, this author cautioned ‘first do no harm.’ In following this approach, APA’s
decision to retain the DSM gender diagnoses appears justified and it has had the
intended effect of improving access to care.133
This tension between pathologization and maintaining access to care is central to the politics of
trans healthcare. How do we balance these two concerns in a context where gender variance must
be pathologized in order to facilitate access to hormone therapy and surgical interventions?
When do we prioritize one over the other?

WPATH and Gatekeeping Today
HBIGDA was renamed the World Professional Association for Transgender Health
(WPATH) in 2006 and remains the leading medical authority on trans health issues in the world.
134

It has since released 7 updated standards of care that have evolved alongside and in concert

with the DSM, substantially relaxing the criteria135 to access a diagnosis and treatment for what
is now known as gender dysphoria, particularly when it comes to accessing hormone therapy. It
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still maintains the gatekeeping model that emerged in the original standards, recommending that
trans people seeking medical services must first consult with a mental health professional. If the
mental health professional diagnoses the person with gender dysphoria, they must write a referral
letter for the person’s desired physician or surgeon.136 One referral from a mental/behavioral
health professional is required to start hormone therapy and/or chest/breast surgery, while genital
surgery requires two referrals, 12 months of continuous hormone therapy, 12 months of the
‘real-life’ test,137 and strongly recommends regular mental health counseling.138
By placing gender dysphoria in the DSM-5 as a mental disorder, all of the ‘symptoms’ of
the disorder are rendered internal struggles that are due to an inherent pathology present in the
trans person. Professor of psychology Sarah Schulz argues that the DSM-5’s description of
gender dysphoria as being characterized by “...clinically significant distress or impairment in
social, occupational, or other important areas of functioning,”139 rules out the reality that this
distress is not due to an inherent condition or pathology, but “...society’s response to
nonnormative gender presentation.”140 Kristen P. Lovell, a black trans woman who grew up in
Yonkers, NY, speaks to this in an interview with the Trans Oral History Project as she recounts
her experiences being bullied and suspended from elementary and middle school:
…when we are grappling with these things, we are the problem. And so, they put
me in a classroom for ‘emotionally disturbed children.’ But it was just like, I’m
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not really emotionally disturbed. I’m disturbed by the fact that I’m being
constantly being harassed on a daily basis…I have no choice but to lash out.141
By segregating Lovell into a ‘special classroom,’ her teachers maintained that the reason that she
lashed out at the children who bullied her was because she had some pathological emotional
issue. The distress she experienced as a result of her harassment by other children’s was thus
taken to be her fault, rather due to the harassment that she underwent because of their reactions
to her nonnormative gender presentation. This logic is profoundly disempowering for trans
people and fails to correctly attribute the source of the ‘distress and impairment in social
functioning’ that many experience. Schulz problematizes this, writing, “...transgender identity
itself is not necessarily a cause of distress, but instead is a valued life experience among
transgender individuals who see being transgender as a way to live a satisfying and meaningful
life.”142
Gatekeeping forces trans people to present self-narratives rooted in distress and
selectively read back on their lives through a lens of pathology, rather than explaining their true
lived experience. Trans activist and attorney Dean Spade reflects on his own experiences
navigating the gatekeeping model,
So now, faced with these questions, how do I decide whether to look back on my
life through the tranny childhood lens, tell the stories about being a boy for
Halloween, about not playing with dolls? What are the costs of participating in
this selective recitation? What are the costs of not participating?143
By forcing trans people to participate in a ‘selective recitation’ of their lives, gatekeepers
actually force them to pathologize themselves. Those who do not are not legible as trans, and are
thus excluded from this category, thereby rendering access to mainstream hormones and surgery
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all but impossible. Additionally, it puts trans people into a position where they are coerced into
performing distress, impairment, and binary gender aspirations in order to be allowed to access
this “world of meaning.”144 Not only does this enforced narrative obscure the trans person’s true
desires and goals for their embodiment, it also renders the therapeutic relationship completely
ineffective as a form of counseling. The goal of any therapeutic relationship should be to build a
relationship based on trust, honesty, and respect for the patient’s autonomy. Here, it is more
interested in perpetuating the gender binary and maintaining medicalization of the trans
experience.
In order to successfully analyze the narratives that trans patients put forth in the
therapeutic setting, mental health professionals often rely on their own subjective understandings
of how gender and transness operate. James Whitehead et al. conducted a study of 35 “trans
positive” therapists in San Francisco and Portland, Oregon and focused on the instances in which
they denied access to hormones or surgery to trans people who came to them seeking
recommendations. One therapist recalled when she denied a letter to a client:
The first time she had come in to see me she says ‘you know, I met a
female-to-male transsexual last week, and I knew instantly that I was a, I needed
to do the same thing. I needed to be a man’. And it never occurred to her before
that. And here she was in her late twenties. Nobody I had ever seen before told me
that, had told me that things occurred in a few hours. I stayed with it for a while,
what I kept trying to get her to do was to talk about her full life with this issue.
And, she kept arguing with me that the forces of the universe were telling her that
she needed to transition. And my alarm’s going off right away that this is not a
standard case, this person needs to not go there. This was a woman; she was a
woman and should stay that way for her own good. And eventually she got fed up
with me because I kept asking her for some particulars about what it must feel
like to be a man; what her history has been.145
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When people enter into a situation with a mental health gatekeeper and do not provide the
scripted narrative that is expected of them, this creates uncertainty on the part of the mental
health professional. Because the gatekeeper felt alarmed by her lack of certainty on the validity
of the claims this client made and their non-standard narrative, she doubled down on her
authority and role as a gatekeeper and blocked access to the desired treatment. What’s more, she
decided that this patient “was a woman” and should “stay that way for her own good,”
completely dismissing that there was any reality to the claims to transness that this client was
making.
One justification for maintaining the gatekeeping model is to ensure that people do not
regret their decision to transition, either as a result of a misdiagnosis or a poor decision, and hold
the provider liable. In one study, 74% of providers interviewed were concerned about trans
patients suing them who regretted their decision to pursue transition-related care.146 Jamison
Green, former president of WPATH and trans man himself, remarks on the necessity of a
therapist’s evaluation: “This is a complex and difficult thing, and if someone wants surgery it can
be important that they slow down just a bit and think about what they’re doing.”147 This logic is
animated partially by the medical doctrine of non-malfeasance, which contains the utmost
principle that medical professionals should follow: ‘first do no harm.’ Gatekeeping suggests that
if trans people wait an appropriate amount of time and talk to mental health professionals, then
they will make a better and more prepared decision regarding whether or not to pursue surgery,
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thus preventing possible regret. Diagnosis is also seen to play a role in preventing regret: if the
patient is carefully evaluated, then information might surface indicating that the person is not
trans and avoid a misdiagnosis that could potentially lead to a mistaken decision to undergo a
transition. This works in line with the logic that transness itself is something that can actually be
diagnosed. In sum, prevention of regret is thus prioritized over all else, including the wellbeing
of the trans person seeking the medical care.
Paddy McQueen, an ethicist and political theorist, problematizes the notion that regret is
somehow linked to flawed decision-making and is to be avoided at all costs. He argues that
withholding medical treatment for fear that a patient might later regret the decision disregards the
autonomy of the patient. “Part of respecting a person’s autonomy is allowing them to make
decisions that could later be regretted, so long as the decision can be justified at the time it is
made.”148 Trans people are thus deprived of a fundamental facet of adult life, which is the power
to make decisions for oneself. Part of being human is to make decisions that we regret. Further,
the anxiety about trans people regretting a decision to undergo hormone or surgical interventions
ignores the fact that the vast majority of trans people do not experience post-transition regret.
Regret rates amongst trans people who undergo hormone therapy are low, with one study
pointing to a .08% prevalence of regret in a group of 1,944 patients, just 17 people, and only 3 of
them took steps to reverse their transitions.149 None who regretted their decision took legal action
against the providers.150
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The therapist-patient relationship does not occur within a vacuum. Race, class, and
gender all inform and shape interactions that take place between the therapist and patient.
Researchers B. Mitchell Peck and Sonya Conner conducted a study that found “...doctor-patient
interactions will be most physician-centered between white physicians and non-white patients,
male physicians and female patients, and for patients from lower socioeconomic backgrounds.”
151

Black trans and trans of color people who seek medical care under the gatekeeping model are

thus subjected to higher levels of medical authority and paternalism in the decision-making
process about their suitability to access transition-related medical services. Sociologist Emily
Allen Paine quotes Corey, a Black 32-year-old nonbinary trans man, “I think there are
interactions where it’s really difficult to tell what’s affecting the treatment...I don’t know what
problem you’re having with me, but you’re having a problem.”152 This confusion and dissonance
on the part of the patient puts them in a position where they are constantly uncertain about what
it is about them that the therapist is attempting to discipline.
Gatekeeping precludes the possibility of fostering an actual therapeutic relationship
between the mental health professional and the trans patient. In other words, the goal of this
therapy is not to provide counseling or guidance for trans people that they might actually benefit
from. Therapists, because their role is to scrutinize, discern, and diagnose, often do not trust their
trans patients and suspect that they are being dishonest.153 Riley, a Filipino-American trans man,

151

B. Mitchell Peck and Sonya Conner, “Talking with Me or Talking at Me? The Impact of Status Characteristics on
Doctor-Patient Interaction” in Sociological Perspectives, Vol. 54, No. 4 (Fall 2011), 547-567. SAGE. Fall 2011.
https://www.jstor.org/stable/10.1525/sop.2011.54.4.547. 552.
152
Emily Allen Paine, “Embodied Disruption: ‘Sorting Out’ gender and nonconformity in the doctor’s office” in
Social Science and Medicine, Volume 221, 352-358. Elsevier. 2018.
153
Shuster, “Performing informed consent in transgender medicine,” 194.

47

describes his encounter with a mental health professional who had never seen a trans client
before:
...it felt like she was going line by line, asking me about my relationship to my
body, my sex life…by that reasoning, concluded that I was actually not trans.
Because I let partners touch me and because I can shower. And her way of
describing to me that she didn’t believe me was that like, well these people do this
and this, and these people can barely do this and that, and so I do not think that
this is what you’re going through.154
As we can see from Riley’s encounter, honesty is dangerous when interacting with gatekeepers,
because no matter how often or how convincingly trans patients explain that they are trans,
unless they reciting the medical trans script they will not be believed by the gatekeeper. Emily
Paine quotes Dana, a 25-year-old Black non-binary person, who reflects on their experiences not
being taken seriously or believed by healthcare providers. “I wonder if the reasons why my pain
is not believed is maybe because of my class background, my race, and the gender that they’re
perceiving me as.”155 Black and trans of color people have a harder time convincing gatekeepers
that they are trans because their lives are not as intelligible as trans under the medical paradigm.
Whatever the reasons why Dana’s healthcare providers do not believe them, their lack of trust for
Dana has a serious impact on Dana’s health and wellbeing. What’s more--distrust for trans
people on the part of gatekeepers creates situations in which access to hormones and surgery can
be refused based on a disbelief in the patient’s self-proclaimed gender identity.
Trans people seeking hormone therapy or surgery are very aware of the gatekeeping
model and have adapted to life under a severe regulatory mechanism for enforcing binary
gender. They recognize that they are being tested and evaluated, so they lie to the best of their
ability. They lie to ‘pass’ the test, successfully convincing the therapist that their ultimate goals
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from treatment is ‘passing’ in the streets. Since Benjamin’s publication of The Transsexual
Phenomenon, trans people have been educating themselves and rehearsing performing what
medical professionals expect them to say.156 Trans author Claudine Griggs wrote in 1998, “I’ll
lie my ass off to get what I have to.”157 When the costs of not lying are so severe that one’s
desired embodiment could be withheld from them, how could they not? Whether it be through
friends, partners, or the internet, Sarah Schulz writes that trans people know what the diagnostic
criteria are and are often “...ready to say what is expected of them to get the letter from the
therapist...”158 Gatekeeping produces highly performative narratives of transness that are
intentioned to satisfy arbitrary diagnostic criteria. As Spade writes, trans people have to “...lie
and cheat their way through the medical roadblocks to get the opportunity to occupy their bodies
in the way they want.”159

Informed Consent
In recent years, trans activists and health care activists have been pushing for uniform
adoption of the informed consent model as a patient-centered alternative to the gatekeeping
model. Informed consent is grounded in the idea that patient autonomy should be respected in the
decision-making process about whether or not to pursue transition-related care, and therefore the
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involvement of a mental health professional is not necessary. In terms of how it looks, the
patient, after hearing benefits, risks, and alternatives associated with a given treatment path,
makes their own decisions about the care they would like to receive. Ruben Hopwood, the
Transgender Health Program Coordinator at Fenway Health, a LGBTQ health clinic in Boston,
described informed consent to a Rewire reporter as follows: “access to medical treatment and
care, individualized and appropriate to that person, without the [prerequisite] requirement of a
mental health professional’s evaluation to access medical care.”160 Informed consent is already
being used in trans healthcare, typically by clinics161 in urban settings162 such as LGBT health
clinics or Planned Parenthood, rather than private or solo practices. Timothy Cavanaugh et al.
advocate for the informed consent model as more “...respectful of the patient’s sense of agency”
163

than the gatekeeping model. They argue that transgender patients should have complete

autonomy in assessing the type of treatment they would like to pursue.
The ideological origins of informed consent can be traced back to The Nuremberg Code,
the result of the Nuremberg trials of Nazi war criminals under international law at the end of
WWII, which sought to establish an end to physicians and scientists’ experimenting on patients
without their consent.164 Its first principle states that in scientific research, “The voluntary
consent of the human subject is absolutely essential.”165 Under this principle, the document states
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the patient should, “...have sufficient knowledge and comprehension of the elements of the
subject matter involved as to enable him to make an understanding and enlightened decision.”
Informed consent, then, is founded on the principle that a patient must be able to legally consent
to a given treatment, procedure, or test, and in order to do this must also have “sufficient
knowledge and comprehension” about the risks and benefits of all available relevant treatments.
The Nuremberg Code and other subsequent attempts to advance informed consent are all
intended to increase patient autonomy, “an ideological principle that patients and test subjects
should have the right to self-determination in health-related matters, and the opportunity to make
free and informed choices about their bodies, health, and lives.”166
Informed consent, although it has clear ethical principles, seems to be difficult for doctors
to follow in practice when it comes to providing treatment to trans patients. Many seem to
misunderstand what informed consent entails.167 One provider who claimed to be using this
model said in an interview with sociologist Stef Shuster,
...you also want to make sure that the person has the capacity to make decisions
about their lives. And with trans people, that becomes a little tricky because
sometimes they don’t want to hear about the risks involved in starting hormone
therapy and how that is going to make their lives difficult.168
This provider was expressing doubt about the capacity that trans people have to make decisions
about their care because they have already decided that they want to pursue a particular treatment
path. But if a person has already dedicated a considerable amount of time to their decision to
pursue a given treatment, their decision has already been made. This doctor is expressing a desire
to be more involved in the decision-making process and have control over its outcome, thereby
rendering “‘autonomy’ a conditional concept” and making it difficult for the trans person to
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make a fully autonomous decision concerning a given treatment.169 Additionally, he is separating
trans people from all other categories of people with the phrase, “...with trans people, that
becomes a little tricky…” and participating in the reification of pathologized trans identity in
which trans people are inherently characterized by their desire to pursue a transition.
Doctors still utilize their subjective judgment and opinions of their patients under the
informed consent model in order to withhold access to treatment. Shuster quotes another
provider, a family physician, who questioned whether or not her new patient, a trans man who
had been on testosterone for ten years and was seeking a refill, was actually listening to the
information she provided during the appointment. “I was concerned about what was his level of
understanding in the consent I was reading to him, and with him? He was nodding along but I
just wasn’t sure he was really listening.” Ultimately, she denied his request to refill his
prescription for testosterone. These types of suspicions are grounded in the providers’ subjective
feelings about whether or not this person is making an appropriate decision to pursue hormone
therapy or surgery. Another provider expressed concerns that his patients were lying to him:
If I’m concerned about trans men because their testosterone levels are really high,
and they’re taking - if I believe them - regular doses, I’ll take a look….So then I
wonder if my patient is taking more than he says he is.170
This providers’ incredibly paternalistic attitude towards his patients effectively squashes his
patient’s autonomy and reinforces his role as a discerning eye that catches disobedience to
medical authority and disciplines it by withholding access to treatment.
In the next chapter, I discuss the various financial barriers to accessing transition-related
care and how privatization of trans healthcare constructs treatment as a product that is separate
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from the diagnosis of gender dysphoria, and functions to distribute access to this product on the
basis of ability to pay.

53

Chapter 3
The Politics of Coverage: Privatization, Health Insurance, and Medical Necessity
In the American market economy, the quest for self-expression increasingly
involved the purchase of goods and services that promised a better life. For the
American transsexual, surgery was such a commodity, a desperately desired
consumer item, available only to those who could afford it.171
Desire, sex, and gender resemble neither the earth nor manufactured products.
Desire, sex, and gender are,in reality, closer to information as an embodied
technosemiotic system. They are living codes. Like information, they defy
ownership because my possession of a fragment (of information, desire, pleasure,
sex, gender) doesn’t take it away from you.172

Accessing transition-related services in the U.S. has always been a matter of whether or
not one is able to afford them; after all, medical care in the U.S. has the highest price tag of any
country in the world.173 By the early 1980s, doctors in the private sphere realized that providing
‘treatment’ for trans people, particularly surgical treatment, was extremely profitable. With the
standards of care to guide and legitimate their work, private practitioners began offering
counseling, hormones, and surgery for trans populations nationwide. The ‘treatment’ for
transsexualism thus because a commodity to be purchased on the free market that was separated
from the diagnosis.
The raising prices of transition-related care functioned to render these services virtually
inaccessible to those who could not afford to pay out of pocket or are uninsured. Privatization of
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trans healthcare in a country that does not provide basic universal health insurance coverage
unevenly distributes life chances across populations, leaving low-income trans people with few
options to access care. It is not surprising, then, that health insurance is one of the main deciding
factors in determining access to hormones and surgery. First, there is the issue that trans people
are disproportionately uninsured, primarily as a result of employment discrimination, rendering
transition-related care all but inaccessible through mainstream medical channels. Second, even
when trans people do have health insurance, it operates as a regulatory mechanism that defines
what constitutes medically necessary treatment for gender dysphoria, and, in the process,
actually constructs gendered bodies. In what ways did privatization transform the availability of
treatment, and why? How do the politics of health insurance coverage construct medically
necessary treatments? What are the consequences of separating the diagnosis ‘gender dysphoria’
from the treatment? Why, to this day, are insurers so reluctant to offer coverage for
transition-related medical care?

Health Insurance
During the age of university-based gender identity clinics, which charged roughly $1,600
total for psychological evaluations, surgery, and hospital care, public and private health
insurance174 provided spontaneous and sporadic coverage for transition-related care, especially
towards the mid to late 1970s.175 As these clinics closed, the 1979 Meyer/Reter study176 brought
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about a wave of federally-funded research177 aimed at proving the ineffectiveness of hormonal
and surgical interventions as treatments for ‘transsexualism,’ which private insurance companies
used as a justification not to cover surgery.178 Following this study, a strange alliance formed
between the Reagan administration, trans exclusionary radical feminists, and conservative
doctors to push policy that would deny coverage for “sex reassignment,” a practice that was
facing mounting pushback from both the left and right by this time.179 In 1981, the National
Center for Healthcare Technology (NCHT), a federally-funded agency that advised the
Department of Health and Human Services on scientific evidence, colluded with anti-trans
feminist Janice Raymond,180 to release a scientific report recommending that ‘transsexual
surgery’ be excluded from coverage under federally-funded plans.181 Following the NCHCT
report, many public and private insurance plans began explicitly excluding ‘transsexual surgery’
from coverage on the grounds that it was “experimental”. The report concludes:
There is a lack of well controlled, long-term studies of the safety and
effectiveness of the surgical procedures and attendant therapies for
transsexualism. There is evidence of a high rate of serious complications of these
surgical procedures. The safety and effectiveness of transsexual surgery as a
treatment of transsexualism is not proven and is questioned. Therefore,
transsexual surgery must be considered still experimental.182
Many things are happening within this statement that ultimately create a separation between the
pathologized transsexual condition and its treatment. First, there is a very questionable
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preoccupation with the ‘safety’ of trans people who undergo these procedures, implying that they
care about the safety of trans people who undergo treatment, while at the same time not
recognizing the reality that many trans people undergo medical transitions partially in order to
ensure against violence and discrimination. Further, many studies had in fact shown that these
procedures had very low rates of complications. Second, how can we measure the
“effectiveness” of these procedures? In the same way that the 1979 Meyer/Reter study measured
the successful adjustment of post-op trans people by how much their lives conformed to
heterosexist, classist, and racist ideologies? By concluding that “transsexual surgery” was not in
fact an effective treatment for “transsexualism,” this NCHCT report left trans people
simultaneously pathologized and without a claim to the procedures that they desired.
The 1980s brought about a world of care in which trans people were faced with, as Dean
Spade describes it, a “double bind,”183 simultaneously medicalized while their medical care was
excluded from coverage. By 1989, Health and Human Services (HHS) issued National Coverage
Determination (NCD) 140.3 explicitly excluding ‘transsexual surgery’ as a treatment for
‘transsexualism’ from coverage under Medicaid on the ground that it was experimental and
therefore not medically necessary.184 Unable to afford the treatment for their condition, many
trans people were and still are indefinitely prevented from accessing the status of ‘good’
transsexuals, the only version intelligible as deserving of sympathy, forever trapped in a state of
unaccepted gender variance that is subjected to constant discipline, control, and punishment.
Trans people was thus established as a condition for which treatment would be inaccessible to all

183

Dean Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People: An Interview with
Advocates,” in Seattle Journal for Social Justice: Transgender Issues and the Law, Vol. 8, no. 2, 497-514. 2010.
502.
184
See footnote 12.

57

except those who could afford it, putting all those who could not in a permanent state of limbo,
weighed down by the financial realities that prevented them from accessing the embodiment they
desired.

Private Industry Capitalizes on ‘Transsexual Surgery’
As discussed in a previous chapter, by 1980, trans healthcare was transferred out of the
university clinic setting into the hands of private practices that mainstreamed the use of the
HBIGDA standards of care. Take, for example, Dr. Stanley Biber, who turned his hometown of
Trinidad, Colorado into the “Sex Change Capital of the World” by the mid 1980s, operating
primarily at San Rafael Hospital.185 His practice, as detailed in a letter to famous gay trans man
and activist Lou Sullivan, followed the standards of care for all patients who sought surgery.
Biber writes,
We require that you have lived, worked and dressed in the male role for a period
of at least one year. We must have a psychiatric evaluation plus we must have one
additional single evaluation either by another psychiatrist or a psychologist.186
As this quote exemplifies, Biber and other private surgeons enforced the use of the standards of
care in the world of private practices. Meyerowitz argues that this was largely performative
professionalism to advance their financial interests: “If they adhered to these guidelines, private
practitioners could protect their professional standing and distinguish themselves from ‘chop
shop’ doctors…”187 Maintaining professional standing was in the best financial interests of these
doctors, who charged $6,225 a pop for vaginoplasty, $3,650 for double mastectomy, and as
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much as $14,300 for phalloplasty. With doctors such as Biber performing up to 100 such
surgeries every year (with vaginoplasty being by far the most common procedure),188 upholding
professional standards allowed them to charge high fees and make the most profit. One trans
woman Biber operated on recalled her reasons for choosing this particular doctor, “Dr. Biber has
a very good record,” she continues, “If I’m going to take the step, I want the best.”189
Transition-related medical care thus became a highly sought after and expensive commodity with
a niche consumer base that bolstered its claims to legitimacy. Having the kind of patients that
can afford to pay out of pocket for your treatments constructs these doctors as especially sought
after and offering the best standard of care, key marketing tactics meant to sell their product.
Though the standards of care provided the illusion of objectivity, doctors’ subjective
decision-making often overrode formal criteria and took precedence over all else. Dr. Biber was
concerned about misdiagnosing his patients, fearful that they might actually be schizophrenics,
extremely feminine homosexuals, or transvestites, rather than true transsexuals.190 In order to
avoid this, he enforced the standards of care for every patient that came in requesting surgery as
a preliminary sorting method. However, as a 1985 New-Orleans Picayune article describes,
“Even after that, Biber goes by his gut feeling and some get turned away.” His gut feeling is
anchored in his years of professional experience: he remarks, “I’ve seen so many that I can
almost count on my gut feeling when they walk through the door.”191 Ultimately, the decision of
whether or not to grant access to care depended on whether Dr. Biber had a bad feeling in his gut
about a certain patient the moment they walked through the door and he was able to scan their
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appearance and mannerisms for the gendered embodiments he was looking for. As Paul Preciado
writes, “The unveiling of gender depends on an optical ontology: the real is what you can see.”192
Gut feelings, as most people understand, are not grounded in scientific knowledge, professional
standards, or expertise: they are the product of personal beliefs, opinions, and prejudices. What
does a true transsexual ‘look’ like, in Dr. Biber’s objective opinion? What do they act like, walk
like, sound like?
In order to maximize profits from transition-related medical care, doctors often required
cash payments up-front to avoid dealing with the unwillingness of health insurance to cover
these procedures. Public insurance, such as Medicare and Medicaid, ruled in 1981 that ‘sex
reassignment’ was cosmetic, elective, and experimental, and thus was to be excluded from
coverage. Most private insurance companies during this time refused to provide coverage for
transition-related surgeries, and even the ones who did provide it were “inconsistent and at times
arbitrary.”193 Dr. Biber remarked in 1989, “...general insurers are giving us a really hard time and
are giving our patients a hard time too.”194 Transition-related care, embodied in the form of sex
and gender, is thus constructed as a marketable, tangible product that consumers would go to
great lengths to pay for, even in the absence of assistance from health insurance. To become a
man or woman, one must “buy” a sex change in order to satisfy this desire. This creates a
scenario in which only trans people who could afford high out-of-pocket prices were able to
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access quality surgical interventions from reputable doctors like Dr. Biber, and all others will
either have to do without or obtain through illicit channels.
In the next section, I discuss the contemporary landscape of health insurance exclusion
for trans people in the U.S., and how the privatization of trans healthcare laid the groundwork for
a reality in which low-income, Black and Latinx trans people are barred from accessing such
services.

Health Insurance and the Distribution of Life Chances
Health insurance, as with all forms of insurance, is a “technology of risk”195 that allows
us to have a sense of security about future uncertainties that might result in loss or harm to our
bodies and possessions. In order to acquire health insurance, one must be able to pay monthly
premiums in order to prepare for unspecified future risk. Colombia professor Geeta Patel argues
that people often form social or political groups based on the risks they face as a group.196 Trans
people, in addition to the risks of violence, death, and unemployment, face the risk of not being
able to access the embodiment in which they imagine themselves living happy and fulfilling
lives.197 Many health insurance plans, it seems, are generally unwilling to insure against this risk
and provide trans people with a measure of security against the uncertainty this arouses within us
and the dangers it subjects us to. Trans people who are unable to buy into an investment against
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future risk are faced with extreme levels of uncertainty unaided. “For someone who is financially
strapped, money that might go unnoticed, automatically subtracted from a paycheck to provision
insurance policies, pension funds or social security, is money that becomes extraordinarily
visible.”198 In the U.S., access to health insurance typically falls along the lines of race and class:
this is also true of the trans population. Of the 14%199 of trans people who reported being
uninsured in the 2015 US Transgender Survey, the sub-populations with the highest rates of
being uninsured were Black (20%), American Indian (18%), and Latino/a (17%).200 Left to face
the uncertainty of being a living person with a body and no health insurance, these populations
are faced with little to no feeling of security in their futures, and at any moment something could
happen with their health that they would not be able to afford treatment for out of pocket. For
these populations, in the absence of health insurance, they are subjected to power that functions
to “distribute life chances across populations,” a kind of power Dean Spade calls “population
management.”201
One of the most striking features of the aforementioned “double-bind”202 is that trans
people are often trapped in a cycle, unable to afford the treatment (particularly hormones, laser
hair removal, and face feminization) that they need to find suitable employment with sustainable
wages. Most of the general U.S. population (56% in 2015)203 accesses health insurance through
employers, with the remainder having some form of public insurance or being uninsured. Trans
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people often have a hard time finding jobs, receiving promotions,204 and maintaining jobs,205 not
least because many states require medical documentation showing proof that a trans person has
undergone surgery in order to change a gender marker on their ID.206 Consider Santos Arce, a
49-year-old Latino trans man, who reflected in an interview about having a hard time finding
work prior to transitioning medically: “...showing up as a young butch to a job interview and
giving those signals, you’re often not going to get the job as a secretary.”207 The inability to
access the very thing that they need to afford to pay out of pocket for transition-related care thus
leaves many trans people, particularly Black trans people, trapped in a state of constant deferral.
Some engage in criminalized sex work or drug dealing in order to pay for medical care from
illicit sources, further subjecting them to violence, incarceration, and risk from unmonitored
hormone use or botched surgeries.208
Excluded and Denied
The landscape of coverage has changed significantly since the the 1980s and 1990s, with
more and more plans offering coverage for transition-related care based on the mounting medical
and legal consensus that it is medically necessary, including Medicaid and Medicare.209 Starting
in 2005 with California, a new wave of state legislation increasingly banned health insurance
discrimination against clients based on their gender identity or expression--meaning, if a plan
covers treatments for other medical conditions, such as a double mastectomy as a treatment for
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breast cancer, then they must cover those same treatments for gender dysphoria. Currently, 21
states and Washington D.C. have laws banning blanket trans exclusion clauses by private
insurance companies.210 With healthcare discrimination based on gender identity being legal in
29 states,211 many trans people routinely212 experience denial of coverage for claims related to
transition-related care: 55% of trans people reported having a claim for surgery denied, and 25%
reported being denied coverage for hormone therapy.213 Take, for example, Arkansas BlueCross
BlueShield’s policy as of January 2017. It reads, “Coverage eligibility of Gender Reassignment
Surgery for Gender Dysphoria is a contract-specific benefit issue. When benefits for gender
reassignment surgery are available, coverage may vary and under some plans may be excluded.”
214

Because

private plans are not legally required to cover the care in Arkansas,215 largely, the

decision about whether or not to provide coverage rests with employers, who can choose plans
that cover the services or not. In more conservative states such as Arkansas, Mississippi, and
Alabama, increased levels of religiosity and social conservatism animate the majority of the
pushback against offering coverage for transition-related healthcare.216
Medical Necessity
The logic of denying coverage is grounded in the notion of “medical necessity,” which
political theorist Daniel Skinner notes “serves as the primary gatekeeper for the utilization of
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health care services.”217 The concept is used by health insurance plans in order to differentiate
between necessary and unnecessary medical care through defining the boundaries of medical
care and cosmetic, elective, or experimental procedures, “in the name of ensuring that patients
receive treatment that is appropriate and medically indicated while also controlling costs.”218
This division between necessary and unnecessary medical care brings us into murky moral
territory. What are medically necessary procedures are necessary for bodies to undergo? What
does it mean to say that the same procedures are necessary for certain bodies but not trans
bodies? Medical treatments for less politically charged pathologies, such as insulin for type I
diabetes, are administered with the goal of achieving a certain result that is related to the
condition, like maintaining healthy blood sugar levels to prevent complications and/or death--in
essence, to sustain life. Treating gender dysphoria with hormone therapy and/or surgery does not
necessarily directly prevent death in the same way, although it has been shown to improve
psychological outcomes.219 Instead, the goal of such a treatment, at least for the trans person, is to
enhance quality of life and achieve their desired embodiment. When insurance plans argue that
these treatments are not medically necessary, they are also arguing that enhancing the quality of
life in this population is not urgent or necessary. Transition-related surgeries are thus
categorically defined by insurers that exclude them from coverage as being in the realm of the
cosmetic or elective, and therefore, not urgent for the person seeking them.
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The Food and Drug Administration (FDA) has not, as of yet, approved hormones as
medications to be used in the treatment of gender dysphoria, despite the fact that numerous
professional associations, including the APA, AMA, and WPATH, have released statements
approving these treatments as “medically necessary,”220 and therefore, not experimental. When
insurance companies deny coverage for hormone therapy on the grounds that it is experimental,
they point to the lack of approval from the FDA for these medications as treatments for gender
dysphoria. One nurse remarked to sociologist Stef Shuster, “You have to realize contextually this
is weird medicine. We’re using non-FDA approved drugs, in non-FDA approved ways.”221
Maintaining the idea that hormone therapy is somehow strange, weird, and experimental affects
trans people twofold, simultaneously stigmatizing the care that they seek and justifying
arguments in favor of withholding coverage.
Further, procedures and treatments that many trans people desire and seek out are
explicitly excluded on the grounds that they are ‘cosmetic’ by providers that do actually offer
coverage for hormones and/or surgery as treatments for gender dysphoria. In so doing, providers
are participating in the construction of gendered bodies. For example, Aetna excludes the
following procedures, among many others, from coverage as treatments for gender dysphoria on
the grounds that they are cosmetic: voice modification surgery, body contouring, hair removal,
and facial masculinization or feminization.222 By only offering coverage for hormone therapy,
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chest/breast surgery, and/or genital surgery, Aetna is participating in constructing what elements
of the body are most essential to alter for trans people to achieve successful embodiment as men
or women, thereby reducing gender to chest, genitals, and blood levels of testosterone or
estrogen. However, as trans political historian Paul Preciado argues,
...the beard and the voice, and not the penis and the vagina or X and Y
chromosomes, are the dominant cultural public signifiers of gender in our society.
Let us cease to speak about men and women and simply say hairy body or smooth
body, body with a high voice or with a low voice.223
For transfeminine people who undergo estrogen therapy, the timbre of their voice does not
change as it does for transmasculine people taking testosterone. Similarly, estrogen does not alter
the presence of existing facial or body hair. Dean Spade writes, “For surviving daily life--work,
school, street interactions--these external markers of gender are far more important than genital
appearance, which is usually only known to one’s closest intimates.”224 Through denying
coverage for hair removal or voice therapy/surgery as treatments for gender dysphoria on the
grounds that they are cosmetic, insurance plans construct these things as inessential to realizing
embodied gender, that is, a vagina makes a woman, not a hairless face or a soft voice. In doing
so, they simultaneously construct themselves as experts on what constitutes gender and gender
itself.
As discussed in a previous chapter, the WPATH standards of care and the DSM-5 gender
dysphoria diagnosis function as gatekeeping mechanisms that ration out care to trans people.
These gatekeeping mechanisms have become embedded within the language of many insurance
plans; Schulz writes, “[t]he Standards of Care...have also been institutionalized at the policy
level by managed-care insurance companies and court systems.”225 Ilhan, a trans man living in
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New York City, reflects on gatekeeping from his health insurance, which he has through a
unionized job:
I’m still definitely going to be covered, which is great. The only issue is that to
qualify for these procedures I need to jump through a lot of hoops. I need to have
two letters from mental health providers...one of them is supposed to have a
specialty in gender therapy, which is really hard to find someone who has
explicitly a speciality in that. I also have to get a letter from a physical healthcare
specialist…226
Despite the New York law mandating that insurance providers cover transition-related medical
care, trans people like Ilhan, who has already had top surgery and been on hormones for quite
some time, still constantly face barriers to accessing care. He continues, “[t]he really hard thing
has been dealing with the mental health stuff…”227 Many insurance plans, as per WPATH
guidelines, require a mental health professional to sign off that they meet the requirements for
gender dysphoria prior to accessing care. Schulz writes,
...mental health practitioners...may not feel comfortable granting access to health
services outside of the context of a longer term therapeutic relationship.
Therefore, the length of therapy may range from a few sessions to months in
therapy, and this length depends largely on how long the mental health
practitioner deems it necessary for the client to attend therapy, not necessarily the
client’s therapeutic goals.228
Trans people like Ilhan are thus in a situation where their ability to even get diagnosed in order to
access the care is complicated by financial constraints. They might be able to afford a small
monthly co-payment for hormones, but not the higher co-pays for counseling sessions with
licensed therapists that could potentially extend for months. Many trans people might not be able
to take time off from their lives in order to travel to and from a therapist and attend a 50-minute
counseling session.
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When coverage for hormone therapy and surgery is denied on the basis that it is not
medically necessary, it is brought into the realm of an individual responsibility, one that the trans
person must bear the financial burden of alone. David Goldhill, writing for the Atlantic, reflects
on arguments related to medical necessity by using the example of the statin he takes for his high
cholesterol.
It's worth thinking about my personal decision for a moment. When I chose a
statin, society subsidized that choice at the point of purchase through the tax
advantages afforded insurance and my health saving account. If I were a Medicare
or Medicaid beneficiary, society's subsidy would have been more direct. Since we
all ultimately pay for these subsidies, we should all care about the choices our
policies encourage.229
In Goldhill’s words, we get to the heart of why Americans care so much about whether or not
health insurance plans provide coverage for transition-related medical care. By framing the
‘choice’ to pursue a certain medical procedure or treatment as an individual choice, he invokes
narratives that are very salient in U.S. culture about personal financial responsibility. Since
taxpayers are subsidizing our healthcare, whether indirectly or directly, society should get to
decide what is covered and what is not, and treatments that should not be covered are those
treatments which are cosmetic or elective, or a matter of individual choice. Taxpayers, he
reasons, should not have to take financial responsibility for the individual choices of people who
refuse to play their part by paying their individual financial responsibilities.
One might think that the answer lies in an attempt on the part of health insurance
companies to cut costs across the board by minimizing the number of procedures they cover
irrespective of the diagnosis or the person seeking them. However, this does not seem to be the
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case: a 2008 study showed that a total annual cost of as little as 17.3¢ per resident and 6.6¢ to
employers would be added if health insurance plans provided coverage for transition-related
care.230 Similarly, a complaint filed by a student at University of Wisconsin School of Medicine
in 2016 over denial of coverage for her gender confirmation surgery noted that state consultants
estimate the total yearly cost for covering such procedures for all trans people on public
insurance in Wisconsin would range between $100,000-$250,000, “less than two-tenths of 1
percent of the health program budget at most.”231 Trans people are a relatively small population,
and so few actually choose to pursue surgical care or hormone therapy in a given year. Providing
coverage for these services, it has been argued, may act as a form preventative care for trans
people, who often experience symptoms associated with having an unmet need for care, such as
anxiety, depression, and suicidality,232 thereby proving more cost-effective in the long-run for
everyone involved.
What is the reason, then, that insurance providers continue to argue in favor of denying
coverage for transition-related care? Dean Spade argues that the power of the major societal
institutions such as education, medicine, insurance, functions not necessarily through
“prohibition or permission but rather through the arrangement and distribution of security and
insecurity.”233 Through denying coverage for transition-related care, insurance companies
produce insecure conditions for trans people in their day-to-day lives, leaving them unable to get
accurate IDs, unable to find jobs, and without safe access to the care they are seeking. Spade
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writes, “Because they are marginalized in employment, and may feel that such healthcare is
urgent, many transgender people engage in criminalized activities such as sex work in order to
raise money to purchase hormones from informal sources.”234 Black trans woman Kristen P.
Lovell recounted her experiences as a sex worker in the late 1990s on Christopher street,
including accessing street hormones. She remembers,
We used to go down to Chi-Chi’s to get it. There was a person at the door, you
would give them some coin, they would take a list and then they would come
back with the Premarin pills, you’d come back in the next few days to see if your
“prescription” was ready.
While Kristen was forced into a position where she had to rely on street hormones she funded
through sex work, this can cause a whole host of problems, particularly health-related, as using
these medications without medical supervision can result in HIV, hepatitis, organ failure, and/or
nerve damage, among other conditions that result from unsupervised injections and unsanitary
needles.235 Black, Latinx, and low-income trans people are disproportionately exposed to these
risks.

Limits of the Non-Discrimination Approach to Trans Exclusionary HealthCare
What the future bodes for legislation on health insurance coverage of transition-related
care is uncertain at the moment, but it is not a steady march towards inclusion. Many have
argued for fighting for coverage at a state or local-level through using non-discrimination law.236
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“We do not think that a federal legislative strategy would be helpful at this time. We think that
locally-based strategies will be most effective and that people in those communities are best situated to
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At the state level, where the vast majority of decisions about healthcare policy are made, there is
a positive trend towards outlawing discriminatory health insurance policies, but in many states
employers are still free to purchase plans that exclude or deny coverage for transition-related
care. The federal situation is also complex: section 1557 of the Affordable Care Act, passed in
2010, banned any plan that received federal funds from discriminating on the basis of sex, which
has been interpreted as covering discrimination on the basis of gender identity. Section 1557
does not require insurers to provide coverage for any particular treatments commonly used for
gender dysphoria. Non-discrimination law seeks to eliminate explicit discrimination from
insurance providers on the basis of diagnosis, rather than targeting the systemic barriers to
accessing healthcare faced by trans people. As previous sections of this chapter have already
argued, even when plans provide coverage there are still major systemic barriers to access built
into health insurance plans. The Trump administration is currently making moves to overturn the
ACA. In late 2018 conservative Texas federal district judge Reed O’Connor requested and was
granted a nationwide prohibition on the enforcement of the rule. HHS is expected to reverse the
regulation on Section 1557 to “redefine discrimination “on the basis of sex” to eliminate
protections based on gender identity and termination of pregnancy.”237
Moving forward, activists and lawyers need to focus on eliminating the intersecting
vectors of oppression that cause systemic barriers for trans people accessing care. There should
be a focus on uniform recognition of transition-related care as medically necessary, as well as
expanding access to health insurance coverage through adoption of a universal single-payer
healthcare system. A non-discrimination approach does little to protect trans people who have no
Katie Keith, “More Courts Rule On Section 1557 As HHS Reconsiders Regulation,” Health Affairs.
https://www.healthaffairs.org/do/10.1377/hblog20181002.142178/full/. Published October 2, 2018. Accessed March
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health insurance in the first place. Already in the preliminary campaigning for the 2020 election,
many candidates are pushing for universal single-payer healthcare. It is likely that the U.S. will
have to grapple with the growing demand for a new healthcare system in the coming years.
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Conclusion: Demedicalizing Transitions
Is it possible to imagine a different reality in which transition-related care is free and easy
to access? Or, better yet, where gender variance is not pathologized? Many trans authors and
activists have taken part in dreaming that pathologization, gatekeeping, and insurance denial are
things of the past, or, better yet, never existed in the first place. What would a trans subjectivity
look and feel like in this context? Feminist trans scholar Sandy Stone, who catalyzed a wave of
trans theory and scholarship with her 1987 Posttranssexual Manifesto, writes,
The highest purpose of the transsexual is to erase h/erself, to face into the
‘normal’ population as soon as possible. Part of this process is known as
constructing a plausible history--learning to lie effectively about one’s past. What
is gained is acceptibility in society. What is lost is the ability to authentically
represent the complexities and ambiguities of lived experience...238
Trans people who cannot access the material embodied existence that they desire are
hypervisible. For those who can, narratives and lives are erased and subsumed by a narrative of
distress and self-hatred that seeks to erase any semblance of gender variance. Stone then asks,
“How, then, can the transsexual speak? If the transsexual were to speak, what would s/he say?”239
How can we move outside of the pathologized position that has been carved out for us, and
imagine our own futures in ways that are not bound to oppressive and binary gender systems
rooted in racism?
Katherine Collins, a trans woman writing in 1994, reflects on the immense gravitational
pull that the desire for surgery has had in her life, bringing with it the sense of “walking toward a
brilliantly lit altar.”240 Once she actually undergoes the procedure, however, reality fell short of
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her expectations. “...the result of this assembly-line process is that the initial spiritual impact of
the event is completely nullified. One arrives here with a certain defensiveness, bearing her
letters, hard-won from a suspicious and begrudging world, and one almost expects to be turned
away at the last minute on some technicality.”241 Trans people are cheated from the potentially
amazing experience of surgically altering your body to reflect the way you see yourself thriving
in the word. Medicalizing this process has completely removed the possibility that it might be
enjoyable and even fun for the person who undergoes it. Profoundly, Collins asks, “...what might
it be like, how much better for all concerned--for all society--if SRS and all medical procedures
were accompanied by an air of spirituality?”
Can we imagine the potential of a demedicalized experience of transition, one that is
democratized and made safe and available to all those who seek to disrupt their gendered
embodiment? She continues,
To take the transsexual process out of the realm of strictly medical, and into the
spiritual realm, would be to entirely eliminate the adversarial obstacle-course that
many transsexuals encounter. To make it a question not of who is crazy and who
is not, and instead to invest it with a series of spiritual counselings, investigations,
and ceremonies, would lead the final SRS initiate to the moment of ritual “blood
sacrifice” with a sense of deep awe and wonder and privilege and responsibility.
What possibilities exist for claiming ownership over this process and reasserting our claims to
our bodies? So many possibilities, both in terms of the experiential and the multiplication of
bodies that do not claim one gender or the other. Transitioning, rather than a movement from one
gender to another, could be a means of experimenting and exploring our many possibilities of
self-actualization.
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